Tag: Dr. Delese Darko
News
Why Ghana was selected for malaria vaccine introduction
According to Dr. Delese Darko, the FDA's Chief Executive Officer, Ghana was selected by the manufacturers of the malaria vaccine because the country has...
News
R21 malaria vaccine receives approval from FDA
The R21 malaria vaccine has been given FDA approval for use in immunizing infants between the ages of 5 and 36 months against malaria...